Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
PARP inhibitor reduces the risk of disease recurrence in BRCA-positive people with high-risk early breast cancer.
Deltra Kroemer, 35, lives in Waterbury, Connecticut, with her five children. She has Stage IV breast cancer.
Breast cancer survivor Marianne Sarcich’s reconstruction surgery was denied by insurance. And denied again. But she persisted and won.
The new study adds to a growing body of research on how diet affects breast cancer survivors’ health.
During the first two years after diagnosis, one third of breast cancer patients said fertility concerns affected their treatment decisions.
These common drugs can curb bone metastasis and may even keep DCIS in check, but side effects make education and awareness crucial.
In the United States, the most common malignancies are expected to be breast cancer, melanoma, lung cancer and colorectal cancer.
An advisory panel reviewed follow-up data on checkpoint inhibitors, voting to maintain four approvals and rescind two.
Studies have shown an alarming drop in screenings—and more advanced cancer—during the COVID-19 pandemic.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
Mixed-size DNA fragments in a blood sample may predict residual cancer as well as MRI scans.
The antibody-drug conjugate is the second drug approved for metastatic breast cancer in the course of a week.
I officially reached the five-year mark of my breast cancer surgery and was flooded with memories on the days leading up to my surgery day.
Health equity advocate Karen Winkfield, MD, MPH, works to enroll more underserved people with cancer in lifesaving clinical trials.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.